Purdue Signs Two Deals To Diversify Portfolio

Purdue Pharma has made headway this month on its 2016-initiated plans to diversify the company's R&D portfolio away from the pain therapy space, having actioned two collaborative deals with Exicure and AnaBios.

Purdue Pharma LP and Exicure Inc. have entered a strategic research collaboration, option and license agreement to discover and develop a treatment for psoriasis.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Deals

More from Business